ROSEN, NATIONAL TRIAL LAWYERS, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation – YS, SMIH
NEW YORK, April 29, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. (NASDAQ: YS, SMIH). SO WHAT: If you purchased YS Biopharma’s securities you may be entitled to compensation without […]